Corporate Presentation Turnstone Biologics Corporate Presentation - November 2024 Poster Presentations 2024 SITC | Enrichment of Tumor-Specific Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) in Gastric Cancer 902.7 KB SITC | Overlap Between Circulating and Intratumoral T Cells As a Predictor of Neoantigen-Reactive TIL Ex-Vivo Expansion 894.1 KB 2023 SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal (CRC) and GI Cancers – In Collaboration with Moffitt Cancer Center 665.8 KB SITC | Enhancing Directly Selected Tumor-Reactive TIL Function Through Genetic Modification 2 MB SITC | TBio BFX 4101 – A Neoantigen Prioritization Pipeline for Selected Tumor-Infiltrating Lymphocyte Therapy 1.6 MB SITC | Tumor Neoantigen Prioritization from Liquid Biopsy Whole Exome Sequencing for Selected Tumor-Infiltrating Lymphocyte Therapy – In Collaboration with Illumina, Inc. 683.8 KB AACR | TIDAL-01: A Selected TIL Process That Enriches for Neoantigen-Reactive TIL in Solid Tumors 732.5 KB AACR | Direct Selection of PD-1+ CD39+ Tumor-Infiltrating Lymphocytes (TIL) from Tumor Dissociates Enrich for Functional Tumor-Reactive Cells 819 KB 2022 SITC | Enrichment of Neoantigen-Reactive TIL in a CRC Patient Sample by FACS: The TIDAL-01 Process 2.2 MB SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal Cancer (CRC) – In Collaboration with Moffitt Cancer Center 1.8 MB 2021 AACR | A Case Study Investigation into the Role of CD4+ Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Patient with a Complete Response to Adoptive Cell Therapy – In Collaboration with Moffitt Cancer Center 13.8 MB
2024 SITC | Enrichment of Tumor-Specific Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) in Gastric Cancer 902.7 KB SITC | Overlap Between Circulating and Intratumoral T Cells As a Predictor of Neoantigen-Reactive TIL Ex-Vivo Expansion 894.1 KB
SITC | Enrichment of Tumor-Specific Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) in Gastric Cancer 902.7 KB SITC | Overlap Between Circulating and Intratumoral T Cells As a Predictor of Neoantigen-Reactive TIL Ex-Vivo Expansion 894.1 KB
2023 SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal (CRC) and GI Cancers – In Collaboration with Moffitt Cancer Center 665.8 KB SITC | Enhancing Directly Selected Tumor-Reactive TIL Function Through Genetic Modification 2 MB SITC | TBio BFX 4101 – A Neoantigen Prioritization Pipeline for Selected Tumor-Infiltrating Lymphocyte Therapy 1.6 MB SITC | Tumor Neoantigen Prioritization from Liquid Biopsy Whole Exome Sequencing for Selected Tumor-Infiltrating Lymphocyte Therapy – In Collaboration with Illumina, Inc. 683.8 KB AACR | TIDAL-01: A Selected TIL Process That Enriches for Neoantigen-Reactive TIL in Solid Tumors 732.5 KB AACR | Direct Selection of PD-1+ CD39+ Tumor-Infiltrating Lymphocytes (TIL) from Tumor Dissociates Enrich for Functional Tumor-Reactive Cells 819 KB
SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal (CRC) and GI Cancers – In Collaboration with Moffitt Cancer Center 665.8 KB SITC | Enhancing Directly Selected Tumor-Reactive TIL Function Through Genetic Modification 2 MB SITC | TBio BFX 4101 – A Neoantigen Prioritization Pipeline for Selected Tumor-Infiltrating Lymphocyte Therapy 1.6 MB SITC | Tumor Neoantigen Prioritization from Liquid Biopsy Whole Exome Sequencing for Selected Tumor-Infiltrating Lymphocyte Therapy – In Collaboration with Illumina, Inc. 683.8 KB AACR | TIDAL-01: A Selected TIL Process That Enriches for Neoantigen-Reactive TIL in Solid Tumors 732.5 KB AACR | Direct Selection of PD-1+ CD39+ Tumor-Infiltrating Lymphocytes (TIL) from Tumor Dissociates Enrich for Functional Tumor-Reactive Cells 819 KB
2022 SITC | Enrichment of Neoantigen-Reactive TIL in a CRC Patient Sample by FACS: The TIDAL-01 Process 2.2 MB SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal Cancer (CRC) – In Collaboration with Moffitt Cancer Center 1.8 MB
SITC | Enrichment of Neoantigen-Reactive TIL in a CRC Patient Sample by FACS: The TIDAL-01 Process 2.2 MB SITC | Expansion and Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes (TIL) from Metastatic Colorectal Cancer (CRC) – In Collaboration with Moffitt Cancer Center 1.8 MB
2021 AACR | A Case Study Investigation into the Role of CD4+ Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Patient with a Complete Response to Adoptive Cell Therapy – In Collaboration with Moffitt Cancer Center 13.8 MB
AACR | A Case Study Investigation into the Role of CD4+ Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Patient with a Complete Response to Adoptive Cell Therapy – In Collaboration with Moffitt Cancer Center 13.8 MB